Long-term Periodontal Tissue Outcome in Regenerated Infrabony and Furcation Defects: a Systematic Review

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2014 Oct 9

PMID 25293498

Citations 2

Authors

Eduardo Aleixo Figueira

Angelica Oliveira de Assis

Sheyla Christinne Lira Montenegro

Diego Moura Soares

Anna Angelica Araujo Barros

Euler Maciel Dantas

Bruno Cesar de Vasconcelos Gurgel

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aimed to systematically evaluate the long-term results of periodontal tissues in regenerated infrabony and furcation defects.

Material And Methods: A search of the Medline database was performed (1960 to 2012), complimented by an additional hand search. For inclusion in the review, clinical trials had to include the long-term evaluation of infrabony and furcation defects submitted to periodontal regeneration for up to 3 years of follow-up. Changes in clinical attachment level (CAL) from pre-surgery, at the first post-surgical, and final evaluations were used to analyze the effects of regenerative treatments over time.

Results: A total of 866 articles were found using the descriptors employed. Of these, 216 papers were selected for abstract reading by two evaluators. One hundred and eighty-nine were excluded for not fulfilling the eligibility criteria. Twenty-seven papers were selected for the analysis of the full texts, and 13 were excluded. Two studies were included after a manual search. Finally, 16 papers were selected for the present review.

Conclusions: Regenerative techniques for the treatment of infrabony and furcation defects resulted in improved CAL during long-term follow-up periods, even when attachment losses occurred during this period. This improvement should be carefully evaluated with regard to its clinical relevance for dental longevity.

Clinical Relevance: The improvement in clinical attachment level achieved by regenerative techniques with biomaterials demonstrated satisfactory results over the long-term. However, regenerative techniques still present different success rates with regard to gain in clinical attachment level.

Citing Articles

Platelet-rich fibrin as an autologous biomaterial for bone regeneration: mechanisms, applications, optimization.

Jia K, You J, Zhu Y, Li M, Chen S, Ren S Front Bioeng Biotechnol. 2024; 12:1286035.

PMID: 38689760 PMC: 11058865. DOI: 10.3389/fbioe.2024.1286035.

Comparison between observer-based and AI-based reading of CBCT datasets: An interrater-reliability study.

Schulze D, Haussermann L, Ripper J, Sottong T Saudi Dent J. 2024; 36(2):291-295.

PMID: 38419982 PMC: 10897586. DOI: 10.1016/j.sdentj.2023.11.001.

References

Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J . New attachment formation in the human periodontium by guided tissue regeneration. Case reports. J Clin Periodontol. 1986; 13(6):604-16. DOI: 10.1111/j.1600-051x.1986.tb00854.x. View

Heijl L, Heden G, Svardstrom G, Ostgren A . Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol. 1997; 24(9 Pt 2):705-14. DOI: 10.1111/j.1600-051x.1997.tb00253.x. View

van der Pauw M, van den Bos T, Everts V, Beertsen W . Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts. J Periodontol. 2000; 71(1):31-43. DOI: 10.1902/jop.2000.71.1.31. View

Orsini M, Orsini G, Benlloch D, Aranda J, Sanz M . Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane. J Periodontol. 2008; 79(9):1630-7. DOI: 10.1902/jop.2008.070282. View

Pretzl B, Kim T, Steinbrenner H, Dorfer C, Himmer K, Eickholz P . Guided tissue regeneration with bioabsorbable barriers III 10-year results in infrabony defects. J Clin Periodontol. 2009; 36(4):349-56. DOI: 10.1111/j.1600-051X.2009.01378.x. View

Kawase T, Okuda K, Yoshie H, Burns D . Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodontal Res. 2000; 35(5):291-300. DOI: 10.1034/j.1600-0765.2000.035005291.x. View

Rivera-Hidalgo F . Smoking and periodontal disease. A review of the literature. J Periodontol. 1986; 57(10):617-24. DOI: 10.1902/jop.1986.57.10.617. View

Warrer K, Karring T, Nyman S, Gogolewski S . Guided tissue regeneration using biodegradable membranes of polylactic acid or polyurethane. J Clin Periodontol. 1992; 19(9 Pt 1):633-40. DOI: 10.1111/j.1600-051x.1992.tb01711.x. View

Stavropoulos A, Karring T . Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial. J Clin Periodontol. 2010; 37(2):200-10. DOI: 10.1111/j.1600-051X.2009.01520.x. View

10.

Nickles K, Ratka-Kruger P, Neukranz E, Raetzke P, Eickholz P . Open flap debridement and guided tissue regeneration after 10 years in infrabony defects. J Clin Periodontol. 2009; 36(11):976-83. DOI: 10.1111/j.1600-051X.2009.01474.x. View

11.

Reynolds M, Aichelmann-Reidy M, Branch-Mays G, Gunsolley J . The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol. 2004; 8(1):227-65. DOI: 10.1902/annals.2003.8.1.227. View

12.

Pretzl B, Kim T, Holle R, Eickholz P . Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. IV. A case series of infrabony defects after 10 years. J Periodontol. 2008; 79(8):1491-9. DOI: 10.1902/jop.2008.070571. View

13.

Parodi R, Santarelli G, Gasparetto B . Treatment of intrabony pockets with Emdogain: results at 36 months. Int J Periodontics Restorative Dent. 2004; 24(1):57-63. View

14.

Cortellini P, Paolo G, Prato P, Tonetti M . Long-term stability of clinical attachment following guided tissue regeneration and conventional therapy. J Clin Periodontol. 1996; 23(2):106-11. DOI: 10.1111/j.1600-051x.1996.tb00542.x. View

15.

Mengel R, Schreiber D, Flores-de-Jacoby L . Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study. J Periodontol. 2006; 77(10):1781-7. DOI: 10.1902/jop.2006.060029. View

16.

Camelo M, Nevins M, Schenk R, Simion M, Rasperini G, Lynch S . Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent. 2003; 18(4):321-31. View

17.

Garrett S, Polson A, Stoller N, Drisko C, Caton J, Harrold C . Comparison of a bioabsorbable GTR barrier to a non-absorbable barrier in treating human class II furcation defects. A multi-center parallel design randomized single-blind trial. J Periodontol. 1997; 68(7):667-75. DOI: 10.1902/jop.1997.68.7.667. View

18.

Okubo K, Kobayashi M, Takiguchi T, Takada T, Ohazama A, Okamatsu Y . Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res. 2003; 38(1):1-9. DOI: 10.1034/j.1600-0765.2003.01607.x. View

19.

Sculean A, Schwarz F, Chiantella G, Donos N, Arweiler N, Brecx M . Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR. J Clin Periodontol. 2007; 34(1):72-7. DOI: 10.1111/j.1600-051X.2006.01007.x. View

20.

De Sanctis M, Zucchelli G . Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy. J Periodontol. 2000; 71(4):606-13. DOI: 10.1902/jop.2000.71.4.606. View